MYOCURE is a H2020 project that aims at developing new therapeutic products based on gene therapy for patients suffering from rare inherited muscle diseases
nTRACK is a H2020 project that aims at multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration
¿Cuáles son las principales ventajas de eCTD sobre NeeS o el papel? ¿Cómo comienzo mi baseline? ¿Cuáles son las fechas de implementación? ¡Conoce todos los detalles de las eSubmissions obligatorias!
What are the main advantages of eCTD over NeeS or paper? How do I start my baseline? What are the timelines?
Find out all the details of the mandatory electronic submissions!
Asphalion is happy to announce that it has been registered by FDA to perform electronic submission to the CVM by the Gateway
The four year Horizon 2020 nTrack project to develop nano-imaging reagents for stem cell tracking and biodistribution is now underway with Asphalion as regulatory partner.